An estimate of the prevalence of dementia in Africa: A systematic analysis

Centre for Population Health Sciences, University of Edinburgh Medical School, Edinburgh, Scotland, UK.
Journal of global health 12/2012; 2(2):20401. DOI: 10.7189/jogh.02.020401
Source: PubMed


The burden of non-communicable diseases is growing, particularly in developing countries. The greatest economic burden is due to dementia, the prevalence of which is rising with increasing longevity. In Africa, where the rate of increase of elderly persons is the fastest in the world, dementia is normally dismissed as a part of normal ageing. The lack of awareness means that many patients are suffering undiagnosed. This review aims to assess the information on the prevalence of dementia in Africa in order to estimate the current burden.
A parallel search of Medline, EMBASE and Global Health limited to post-1980 found only 10 relevant studies. Data on prevalence and risk factors were extracted and analysed. We modelled the available information and used the UN population figures for Africa to determine the age-specific and overall burden of dementia.
The overall prevalence of dementia in adults older than 50 years in Africa was estimated to be about 2.4%, which translates to 2.76 million people living with a disease in 2010. About 2.10 millions of them live in Sub-Saharan Africa. Prevalence was the highest among females aged 80 and over (19.7%) and there was little variation between regions. Alzheimer disease was the most prevalent cause of dementia (57.1%) followed by vascular dementia (26.9%). The main risk factors were increasing age, female sex and cardiovascular disease.
Information on dementia prevalence in Africa is very limited. Further research will not only provide a more reliable estimate of prevalence, and consequently the burden of disease, but will also raise awareness of the problem. This is critical in promoting help-seeking behaviour and generating the political commitment to make dementia a public health priority in Africa.

Download full-text


Available from: Davies Adeloye, Feb 06, 2014
  • Source
    • "This would inform policymakers, health planners, scientists and the general public about the significance of the problem, potentially leading to the development of more capacity-building and cross-sector collaborative efforts to address the issues (Mutabaruka et al. 2011). Currently, there is uneven representation of African countries and specific populations in neurological and neuropsychiatric disease epidemiology reports (Baxter et al. 2013; Blanckenberg et al. 2013; George-Carey et al. 2012; Lekoubou et al. 2014; Olayinka and Mbuyi 2014; Quansah and Karikari 2015). Global disease surveillance systems such as the "
    [Show abstract] [Hide abstract]
    ABSTRACT: Neurological and neuropsychiatric diseases account for considerable healthcare, economic and social burdens in Ghana. In order to effectively address these burdens, appropriately-trained scientists who conduct high-impact neu-roscience research will be needed. Additionally, research directions should be aligned with national research priorities. However, to provide information about current neuroscience research productivity and direction, the existing capacity and focus need to be identified. This would allow opportunities for collaborative research and training to be properly explored and developmental interventions to be better targeted. In this study, we sought to evaluate the existing capacity and direction of neuroscience-related research in Ghana. To do this, we examined publications reporting research investigations authored by scientists affiliated with Ghanaian institutions in specific areas of neuroscience over the last two decades (1995–2015). 127 articles that met our inclusion criteria were systematically evaluated in terms of research foci, annual publication trends and author affiliations. The most actively-researched areas identified include neurocognitive impairments in non-nervous system disorders, depression and suicide, epilepsy and seizures, neurological impact of substance misuse, and neurological disorders. These studies were mostly hospital and community-based surveys. About 60 % of these articles were published in the last seven years, suggesting a recent increase in research productivity. However, data on experimental and clinical research outcomes were particularly lacking. We suggest that future investigations should focus on the following specific areas where information was lacking: large-scale disease epidemiology, effectiveness of diagnostic platforms and therapeutic treatments, and the genetic , genomic and molecular bases of diseases.
    Full-text · Article · Sep 2015 · Metabolic Brain Disease
  • Source
    • "In the past two decades, a dramatic decrease of uneducated people in the elderly have been driving the decrease of dementia prevalence, particularly in the 1990s before population aging began to accelerate in Korea. On the contrary, 10-yr increase of life expectancy in the past two decades have been driving the increase dementia prevalence in the same period since dementia prevalence generally doubles every 5 yr after the age of 65 yr (21). Korea began to move rapidly from an aging society to a super-aged society since 2000. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Through a systematic review and meta-analysis of epidemiological studies on dementia, we assessed the prevalence of dementia and its subtypes-Alzheimer' disease (AD) and vascular dementia (VaD)-in Korea. We searched for epidemiological studies on dementia published in 1990-2013 using PubMed, Scopus, EMBASE, KoreaMed, KISS, and RiCH. Dementia prevalence in elderly patients (aged≥65 yr) was 9.2% (95% confidence interval [CI], 8.2%-10.4%) from 11 studies, which was higher than those from Western and other Asian countries. AD was the most prevalent dementia type, with a prevalence of 5.7% (95% CI, 5.0%-6.4%) from 10 studies compared with 2.1% (95% CI, 1.6%-2.7%) for VaD from 9 studies. The age-specific prevalence of dementia approximately doubled with each 5.8-yr increase of age. Although a significant increasing trend of dementia prevalence was not observed, it increased slightly from 7.3% to 8.7% after 2005; AD prevalence increased after 1995 and VaD prevalence decreased after the early 2000s. The AD/VaD ratio increased from 1.96 in the early 1990s to 4.13 in the 2010s, similar to the worldwide ratio. Owing to this high prevalence in the aging population, dementia will impose significant economic burdens to Korean society. Graphical Abstract
    Full-text · Article · Jul 2014 · Journal of Korean Medical Science
  • Source

    Full-text · Article · Dec 2012
Show more